NUTX
Nutex Health·NASDAQ
--
--(--)
--
--(--)
7.49 / 10
Outperform
Nutex Health demonstrates favorable fundamentals, scoring 7.5/10. Key strengths include robust year-over-year growth in earnings per share (604.19% basic, 564.40% diluted) and net cash flow from operating activities (481.19% per share). Metrics like Asset-MV (-0.50) and Revenue-MV (1.12) place the company in performance group 4, historically associated with positive returns. Overall, the fundamental case is constructive and optimistic.
Analysis Checks(10/10)
Revenue-MV
Value1.12
Score2/3
Weight4.22%
1M Return2.84%
Value1.12
Score2/3
Weight4.22%
1M Return2.84%
Net income-Revenue
Value0.94
Score3/3
Weight14.13%
1M Return6.40%
Value0.94
Score3/3
Weight14.13%
1M Return6.40%
Total profit (YoY growth rate %)
Value18608.29
Score3/3
Weight12.17%
1M Return6.14%
Value18608.29
Score3/3
Weight12.17%
1M Return6.14%
Diluted earnings per share (YoY growth rate %)
Value564.40
Score3/3
Weight10.11%
1M Return5.10%
Value564.40
Score3/3
Weight10.11%
1M Return5.10%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value719.47
Score3/3
Weight8.02%
1M Return4.09%
Value719.47
Score3/3
Weight8.02%
1M Return4.09%
Net cash flow from operating activities per share (YoY growth rate %)
Value481.19
Score3/3
Weight10.56%
1M Return5.16%
Value481.19
Score3/3
Weight10.56%
1M Return5.16%
Basic earnings per share (YoY growth rate %)
Value604.19
Score3/3
Weight9.35%
1M Return4.75%
Value604.19
Score3/3
Weight9.35%
1M Return4.75%
Net cash flow from operating activities (YoY growth rate %)
Value669.45
Score3/3
Weight10.80%
1M Return5.21%
Value669.45
Score3/3
Weight10.80%
1M Return5.21%
Asset-MV
Value-0.50
Score2/3
Weight5.36%
1M Return3.30%
Value-0.50
Score2/3
Weight5.36%
1M Return3.30%
Cash-MV
Value1.58
Score3/3
Weight15.29%
1M Return7.22%
Value1.58
Score3/3
Weight15.29%
1M Return7.22%
Revenue-MV
Value1.12
Score2/3
Weight4.22%
1M Return2.84%
Value1.12
Score2/3
Weight4.22%
1M Return2.84%
Net cash flow from operating activities per share (YoY growth rate %)
Value481.19
Score3/3
Weight10.56%
1M Return5.16%
Value481.19
Score3/3
Weight10.56%
1M Return5.16%
Net income-Revenue
Value0.94
Score3/3
Weight14.13%
1M Return6.40%
Value0.94
Score3/3
Weight14.13%
1M Return6.40%
Basic earnings per share (YoY growth rate %)
Value604.19
Score3/3
Weight9.35%
1M Return4.75%
Value604.19
Score3/3
Weight9.35%
1M Return4.75%
Total profit (YoY growth rate %)
Value18608.29
Score3/3
Weight12.17%
1M Return6.14%
Value18608.29
Score3/3
Weight12.17%
1M Return6.14%
Net cash flow from operating activities (YoY growth rate %)
Value669.45
Score3/3
Weight10.80%
1M Return5.21%
Value669.45
Score3/3
Weight10.80%
1M Return5.21%
Diluted earnings per share (YoY growth rate %)
Value564.40
Score3/3
Weight10.11%
1M Return5.10%
Value564.40
Score3/3
Weight10.11%
1M Return5.10%
Asset-MV
Value-0.50
Score2/3
Weight5.36%
1M Return3.30%
Value-0.50
Score2/3
Weight5.36%
1M Return3.30%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value719.47
Score3/3
Weight8.02%
1M Return4.09%
Value719.47
Score3/3
Weight8.02%
1M Return4.09%
Cash-MV
Value1.58
Score3/3
Weight15.29%
1M Return7.22%
Value1.58
Score3/3
Weight15.29%
1M Return7.22%
Is NUTX undervalued or overvalued?
- NUTX scores 7.49/10 on fundamentals and holds a Discounted valuation at present. Backed by its 18.82% ROE, 26.83% net margin, 12.54 P/E ratio, 1.61 P/B ratio, and 340.02% earnings growth, these metrics solidify its Outperform investment rating.
